Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Concomitant Idiopathic Pulmonary Fibrosis and Lung Cancer: An Updated Narrative Review. | Adv Respir Med | 2025 | 40862703 | PubTator, text mining | PubMed |
| MALT lymphoma affecting the oral cavity: a clinical, pathologic and genetic study of MALT1 gene translocation. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2025 | 40858407 | PubTator, text mining | PubMed |
| To The Editor a Novel Mutation in MALT1 Deficiency. | J Clin Immunol | 2025 | 40853399 | PubTator, text mining | PubMed |
| Crystal-storing histiocytosis associated with MALT Lymphoma: a case report and literature review. | Ann Med Surg (Lond) | 2025 | 40851958 | PubTator, text mining | PubMed |
| MALToma with a 'B'-Not for Benign, but for Bronchus-Associated: A Rare Case of Bronchus-Associated Lymphoid Tissue Lymphoma. | J Investig Med High Impact Case Rep | 2025 | 40831416 | PubTator, text mining | PubMed |
| Postpartum colonic squamous cell carcinoma with a BRAFV600E mutation: a case report. | J Med Case Rep | 2025 | 40826135 | PubTator, text mining | PubMed |
| Butyrate protects against myocardial ischemia injury and cardiomyocyte pyroptosis by inhibiting MALT1-mediated Nrf2 ubiquitination and degradation. | J Mol Histol | 2025 | 40779176 | PubTator, text mining | PubMed |
| Emodin Alleviates Sepsis-Induced Multiorgan Damage by Inhibiting NETosis through Targeting Neutrophils BCL-10. | Adv Sci (Weinh) | 2025 | 40779122 | PubTator, text mining | PubMed |
| Loss of MALT1 Function in a Patient With Combined Immunodeficiency: a Novel Pathogenic Variant and Immunological Insights. | J Clin Immunol | 2025 | 40748513 | PubTator, text mining | PubMed |
| Histiocytic Sarcoma Arising in a Background of Nodular Lymphocyte Predominant Hodgkin Lymphoma. | Case Rep Hematol | 2025 | 40740618 | PubTator, text mining | PubMed |
| From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes. | Pharmaceuticals (Basel) | 2025 | 40732273 | PubTator, text mining | PubMed |
| Chronic Lymphocytic Leukemia: Novel Therapeutic Targets Under Investigation. | Cancers (Basel) | 2025 | 40723181 | PubTator, text mining | PubMed |
| Breaking the oncogenic link: BCL10-MALT1 disruption as a precision strike against NF-κB-driven lymphomas. | Med Oncol | 2025 | 40684038 | PubTator, text mining | PubMed |
| Increased burden of rare variants in GWAS associated genes in familial multiple sclerosis. | Sci Rep | 2025 | 40592943 | PubTator, text mining | PubMed |
| The Tandem Reconnection and Cusp Electrodynamics Reconnaissance Satellites (TRACERS) Mission Design. | Space Sci Rev | 2025 | 40584405 | PubTator, text mining | PubMed |
| Primary mucosa associated lymphoid tissue lymphoma of the gallbladder: A case report and review of literature. | World J Clin Cases | 2025 | 40574919 | PubTator, text mining | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| Novel MALT1 Inhibitors for Treating Cancer. | ACS Med Chem Lett | 2025 | 40529058 | PubTator, text mining | PubMed |
| Blood MALT1 expression levels reflect the lymph node stage and disease-free survival in patients with non-small cell lung cancer. | Oncol Lett | 2025 | 40503039 | PubTator, text mining | PubMed |
| The CARD14sh-BCL10-MALT1 complex regulates MAVS-mediated antiviral response in keratinocytes. | Proc Natl Acad Sci U S A | 2025 | 40489607 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=4